CSIMarket Company Name, Ticker, Customers, else..
 

Xbiotech Inc   (NASDAQ: XBIT)

Xbiotech Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

XBIT Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Xbiotech Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 19.62 %, recorded in the same quarter.

• List of XBIT Competitors





Revenue Growth Comparisons




Net Income Comparison

Xbiotech Inc , slower than the average decrease reported by the company's competitors of -30.11 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -30.11 %

<<  XBIT Stock Performance Comparisons





*Market share is calculated based on total revenue.

  News about Xbiotech Inc Contracts

XBiotech Unveils Ambitious Plans for State-of-the-Art R&D Facility, Bolstering Innovation in Biotechnology

January 4, 2024
 XBiotech Inc., a leading biotechnology company based in Austin, Texas, has set its sights on significant growth with the announcement of plans to construct a state-of-the-art research and development facility. The company has received approval from the City of Austin and is set to commence excavation and site preparation for this groundbreaking project in the first quarter of 2024.The decision to expand the XBiotech campus headquarters and invest in a new RandD facility underscores the company s commitment to innovation and advancing the frontiers of medical science. With research and development being the lifeblood of biotechnology, this expansion is poised to propel XBiotech to the forefront of the industr...





Publicly Traded Peers of Xbiotech Inc




Mereo Biopharma Group Plc
Share Performance



-84.93%
One Year
Mereo Biopharma Group Plc
Profile

Mereo Biopharma Group Plc's business model focuses on the development and commercialization of innovative therapeutics for rare diseases.

More about Mereo Biopharma Group Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 42.784 mill. $ - mill. $ -35.710 mill.


Jazz Pharmaceuticals Plc
Share Performance



+93.34%
One Year
Jazz Pharmaceuticals Plc
Profile

Jazz Pharmaceuticals Plc is a biopharmaceutical company focused on developing and commercializing innovative therapies for a range of medical conditions. Their business model revolves around conducting extensive research and development to identify novel molecules and compounds that can address unmet medical needs. By leveraging strategic partnerships, acquisitions, and licensing agreements, they aim to bring these therapies to market and provide valuable treatment options to patients worldwide.

More about Jazz Pharmaceuticals Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 16,569.948 mill. $ 4,438.645 mill. $ 29.493 mill.


Iterum Therapeutics Plc
Share Performance



+435.71%
Over The Past 5 Days
Iterum Therapeutics Plc
Profile

Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.

More about Iterum Therapeutics Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3.435 mill. $ - mill. $ -26.961 mill.


Innoviva Inc
Share Performance



-0.95%
30 Days
Innoviva Inc
Profile

Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products.

More about Innoviva Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,762.314 mill. $ 394.185 mill. $ 504.344 mill.


Indaptus Therapeutics Inc
Share Performance



-58.21%
This Year
Indaptus Therapeutics Inc
Profile

Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.

More about Indaptus Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 12.545 mill. $ - mill. $ -18.858 mill.

124 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Xbiotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Xbiotech Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.